Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 4.1

The market opened in the red on April 21, 2020, overall volumes in futures & options currently stand at 1,41 crore contracts with a turnover of Rs. 7,46,761.67 crore.

Infosys report dismal numbers; refrains revenue guidance
Infosys report dismal numbers; refrains revenue guidance

Infosys report dismal numbers; refrains revenue guidance

Amir Shaikh Article rating: 5.0

Infosys reported its last quarter numbers for FY20 on Monday. Its revenue for the quarter came in at Rs 23,267 crore as compared to Rs 23,092 crore in the preceding quarter

Markets set for a gap-down opening
Markets set for a gap-down opening

Markets set for a gap-down opening

Karan Dsij Article rating: 4.7

Global markets are reeling under a selling pressure; blame it on the crashed oil prices. The historic negative oil prices are clear gloomy signs about the outlook of global economy as a consequence of COVID-19 pandemic.

Index trend and stocks in action on April 21, 2020
Index trend and stocks in action on April 21, 2020

Index trend and stocks in action on April 21, 2020

Karan Dsij Article rating: 5.0

The level of 9,400 is likely to act as a stiff resistance. On the other hand, support is seen around 9,090 level, followed by 9,000 mark. Stocks in news: Morepen Laboratories, TCS, Infibeam Avenues, Heildelberg Cement, L&T.

IRB Infra resumes toll collection
IRB Infra resumes toll collection

IRB Infra resumes toll collection

Geyatee Deshpande Article rating: 4.3

From today onwards, the nationwide lockdown in India, which was implemented to curb the spread of COVID-19 pandemic, has been eased a little. This has allowed travel to be resumed, following which, IRB Infrastructure Developers announced the resumption of user fee collection at all toll plazas.

Wockhardt receives USFDA QIDP status for WCK 6777
Wockhardt receives USFDA QIDP status for WCK 6777

Wockhardt receives USFDA QIDP status for WCK 6777

Geyatee Deshpande Article rating: 3.8

Wockhardt announced that the company has received qualified infectious disease product (QIDP) designation for WCK 6777 from United States Food & Drug Administration (USFDA). WCK 6777 is once-a-day combination antibiotic of β-lactam enhancer.

Strides Pharma receives USFDA nod for Flucytosine capsules
Strides Pharma receives USFDA nod for Flucytosine capsules

Strides Pharma receives USFDA nod for Flucytosine capsules

Anthony Fernandes Article rating: 4.8

Strides Pharma Science Limited informed the bourses on Monday that its wholly-owned subsidiary-Strides Pharma Global Private Limited (Singapore) has received an approval for Flucytosine capsules USP, 250 mg and 500 mg from United States Food & Drug Administration (USFDA).

Planning to invest in equity MFs currently? Read this!
Planning to invest in equity MFs currently? Read this!

Planning to invest in equity MFs currently? Read this!

Henil Shah Article rating: 4.0

The recent market correction has made people invest more in the equities. However, there are certain things you need to know before investing in equity MFs. Read on to find out more.

Eros International shares jump after merging with STX Entertainment
Eros International shares jump after merging with STX Entertainment

Eros International shares jump after merging with STX Entertainment

Avalokita Pandey Article rating: 3.4

The shares of Indian motion picture company, Eros International Media Limited, jumped around ten per cent on Monday after the company announced an all-share merger with Hollywood’s STX Entertainment to create a global entertainment company.

TVS Motor shines post acquiring Norton Motorcycles
TVS Motor shines post acquiring Norton Motorcycles

TVS Motor shines post acquiring Norton Motorcycles

Avalokita Pandey Article rating: 4.3

Indian multinational motorcycle company, TVS Motor, surged around seven per cent in the early trading hours on Monday after the company announced that it has acquired Britain’s Norton Motorcycles for GPB 16 million (Rs 153.12 crore).

RSS
First23002301230223032305230723082309Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR